Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes
Annals of Internal Medicine · 2023
DOI: 10.7326/m22-2751 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Tadarro L Richardson und 7 weiteren Autor:innen. Beteiligte Einrichtung: VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Medicine, Vanderbilt University Medical Cen…. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Diabetes Mellitus, Type 2, Cardiovascular Diseases, Veterans. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NIDDK NIH HHS, HSRD VA.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee (T.L.R., A.M.H., T.A.E.).
- VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee (A.E.H., A.J.H., R.G.).
- VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee (C.G.G.).
- VA Tennessee Valley Healthcare System Geriatric Research Education Clinical Center (GRECC); and Departments of Medicine and Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee (C.L.R.…
ORCID-Profile: Tadarro L Richardson, Alese E Halvorson, Adriana M Hung, Robert Greevy, Tom A Elasy, Christianne L Roumie
Förderung
- CSRD VA
- NIDDK NIH HHS
- HSRD VA
Zitieren
APA
Richardson, T. L., Halvorson, A. E., Hackstadt, A. J., Hung, A. M., Greevy, R., Grijalva, C. G., Elasy, T. A., & Roumie, C. L. (2023). Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes. Annals of Internal Medicine. https://doi.org/10.7326/m22-2751
Vancouver
Richardson TL, Halvorson AE, Hackstadt AJ, Hung AM, Greevy R, Grijalva CG, et al. Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes. Annals of Internal Medicine. 2023. doi:10.7326/m22-2751
BibTeX
@article{Richardson2023,
author = {Richardson, Tadarro L and Halvorson, Alese E and Hackstadt, Amber J and Hung, Adriana M and Greevy, Robert and Grijalva, Carlos G and Elasy, Tom A and Roumie, Christianne L},
title = {Primary Occurrence of Cardiovascular Events After Adding Sodium–Glucose Cotransporter-2 Inhibitors or Glucagon-like Peptide-1 Receptor Agonists Compared With Dipeptidyl Peptidase-4 Inhibitors: A Cohort Study in Veterans With Diabetes},
journal = {Annals of Internal Medicine},
year = {2023},
doi = {10.7326/m22-2751}
}
EUVIMED